CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 240 filers reported holding CONMED CORP in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $33,412 | +0.8% | 482 | +16.4% | 0.00% | – |
| Q1 2024 | $33,153 | -33.3% | 414 | -8.8% | 0.00% | -100.0% |
| Q4 2023 | $49,718 | +40.9% | 454 | +29.7% | 0.00% | 0.0% |
| Q3 2023 | $35,298 | -25.8% | 350 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $47,562 | +30.8% | 350 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $36,351 | +17.2% | 350 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $31,024 | +10.8% | 350 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $28,000 | -17.6% | 350 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $34,000 | -34.6% | 350 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $52,000 | +4.0% | 350 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $50,000 | +8.7% | 350 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $46,000 | -4.2% | 350 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $48,000 | -99.9% | 350 | -50.0% | 0.00% | 0.0% |
| Q1 2021 | $91,414,000 | +234294.9% | 700 | +100.0% | 0.00% | 0.0% |
| Q4 2020 | $39,000 | +39.3% | 350 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $28,000 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |